Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries
World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV. To assess the impleme...
Saved in:
Published in | PloS one Vol. 11; no. 4; p. e0153243 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
13.04.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV.
To assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries.
Survey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa.
ICF using symptom-based screening was performed at 38% of sites; 45% of sites used symptom-screening plus additional diagnostics. IPT at enrollment or ART initiation was implemented in only 17% of sites, with 9% of sites providing IPT to tuberculin-skin-test positive patients. Infection control measures varied: 62% of sites separated smear-positive patients, and healthcare workers used masks at 57% of sites. Only 12 (26%) sites integrated HIV-TB services. Integration was not associated with implementation of TB prevention measures except for IPT provision at enrollment (42% integrated vs. 9% non-integrated; p = 0.03).
Implementation of TB screening, IPT provision, and infection control measures was low and variable across regional HIV treatment sites, regardless of integration status. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: Timothy R. Sterling reports past grant support to Vanderbilt University from Pfizer, Bristol Myers Squibb and Virco. Timothy R. Sterling has acted as a consultant to Sanofi-Aventis, is a member of a Data Safety Monitoring Board for Otsuka, and receives royalties from UpToDate for textbook chapters on TB/HIV. All other authors declare that they have no competing interests. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: MKC MLL CWW M. Blevins TS ND JD DA ND BC GN CC M. Ballif LF. Analyzed the data: MKC MLL CWW M.Blevins. Wrote the paper: MKC MLL CWW M. Blevins TS ND JD DA ND BC GN CC M. Ballif LF. Approved the final version of the manuscript: MKC MLL CWW M. Blevins TS ND JD DA ND BC GN CC M. Ballif LF. Membership of the International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration is provided in S1 File. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0153243 |